Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia
Daniel A. González‐Padilla, Alejandro González-Díaz, Félix Guerrero‐Ramos, A. Rodríguez-Serrano, E. García-Jarabo, Magdalena Corona, A. Rodrı́guez-Antolı́n, Felipe Villacampa
Topics & Concepts
MedicineCommon Terminology Criteria for Adverse EventsAdjuvantAdverse effectBladder cancerObservational studyMitomycin CQuality of life (healthcare)Internal medicineCancerUrologySurgeryNursingBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments